Paul A. Marks, MD Present Emeritus and Member, Sloan-Kettering Cancer Institute Memorial Sloan-Kettering Cancer Center Dr. Paul A. Marks is President Emeritus of Memorial Sloan-Kettering Cancer Center (MSKCC) and a member of the Sloan-Kettering Institute (SKI). He received his A.B. and M.D. degrees from Columbia and postdoctoral training at the NIH (’53-’55) and the Pasteur Institute (’61-’62). At Columbia College of P&S (1955-80) he was Frode Jensen Professor of Medicine and Human Genetic (1967-80), first Chairman of the Department of Human Genetic (’68-’70), Dean of the Faculty of Medicine (1970-73) V.P. Health Sciences and Director of the Comprehensive Cancer Center (1973-80). In 1980 he became the first President and CEO of the combined MH and SKI-MSKCC – retiring in December, 1999. Since January, 2000 he has been a Member of MSKCC. Dr. Marks has published over 400 scientific articles in various scholarly journals. Over the past three decades his research has focused on the role of histone deacetylase inhibitors (HDACs), anti-cancer agents, including the discovery of the HDACi, suberoylanilide hydroxamic acid, the first of its class to be approved by the FDA for use in therapy of specific cancers. His many honors include member of the National Academy of Sciences; American Philosophical Society; Institute of Medicine; American Academy of Arts and Sciences; Distinguished Achievement Medal of Columbia University; Japan Foundation for the Promotion of Cancer Research Medal, honorary degrees from several universities, Lifetime Achievement Award of N.Y. Academy of Medicine; and the President’s National Medal of Science (USA).
Biography Updated on 27 December 2010